Use of modified chimeric polypeptides

Details for Australian Patent Application No. 2005201365 (hide)

Owner Regeneron Parmaceuticals, Inc.

Inventors Papadopoulos, Nicolas J.; Wiegand, Stanley

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005201365

Parent 779303

Filing date 31 March 2005

Wipo publication date 28 April 2005

Acceptance publication date 9 August 2007

International Classifications

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

14 April 2005 Complete Application Filed

28 April 2005 Application Open to Public Inspection

  Published as AU-B-2005201365

9 August 2007 Application Accepted

  Published as AU-B-2005201365

6 December 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005201366-Predictive lossless coding of images and video

2005201364-Fluid dispenser